Top Markets
#1 MowCat MowCat +49.06%
#2 Velvet Velvet +37.57%
#3 Derive Derive +19.79%
#4 Audiera Audiera +18.76%
#5 Quack AI Quack AI +18.38%
#6 Bermuda Shorts Bermuda Shorts +15.44%
#7 aPriori aPriori +14.44%
#8 Biconomy Biconomy +14.37%
#9 Cross Cross +12.38%
#10 MarsCoin MarsCoin +12.30%
Coin of the day
MowCat MowCat
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Hisse Senetlerindeki Sıralama #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Hisse Fiyatı
$1.85
Son senkronizasyon: 2024-08-19
Piyasa Değeri
$3.96M
Değişim (1 gün)
2.78%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret MyMD Pharmaceuticals, Inc. (MYMD)

Kategori

Healthcare
MyMD Pharmaceuticals, Inc. (MYMD) için gelir
Aug 2026 itibarıyla gelir TTM: 0
MyMD Pharmaceuticals, Inc. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
MyMD Pharmaceuticals, Inc. için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE